🇺🇸 FDA
Drug

rituximab-arrx

Brand: RIABNI

approved

Quick answer

rituximab-arrx (RIABNI), is a pharmaceutical active ingredient, with approved status in the US.

Key facts

INN
rituximab-arrx
Brand
RIABNI
Route
INJECTION
Formulation
INJECTABLE

Related news

FDA Approves Riabni Biosimilar: Expanding NHL Treatment Options
NewsOncologyApr 20, 2026

FDA Approves Riabni Biosimilar: Expanding NHL Treatment Options

The FDA's approval of Riabni as a biosimilar for non-Hodgkin lymphoma (NHL) marks a significant advancement in treatment options for patients.

Dr. Sarah Mitchell

Frequently asked questions

What is rituximab-arrx?

rituximab-arrx (RIABNI), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for rituximab-arrx?

RIABNI is a marketed brand name for rituximab-arrx. Check FDA Drugs@FDA for the current US label holder.